Hereditary pancreatic cancer [14 genes]

10-15% of pancreatic cancer are due to a predisposition syndrome towards hereditary cancer, such as hereditary breast and ovarian cancer, familial melanoma, Lynch syndrome, familial adenomatous polyposis, Peutz-Jeghers syndrome, or Li-Fraumeni syndrome. The remaining 85-90% do not present a recognizable genetic syndrome and are considered as familial pancreatic cancer (FPC). The recommended genetic study strategy is, therefore, to carry out a differential diagnosis of the main syndromes by sequencing genes like BRCA1, BRCA2, PALB2, CDKN2A, MLH1, MSH2, MSH6, APC, STK11, and TP53, among others.

Request study Informed consent
Steps to follow
Steps to follow

How to order

1. Download & fill out

Please cover as many fields as possible in both documents

2. Sample collection

Three sample types: saliva, peripheral blood or genomic DNA

3. Pack the sample

Please pack the sample in a way to prevent leakage

4. Send the sample & the request

Please schedule the delivery for Monday–Friday: 8am – 5pm

5. Result: the report

Via: e-mail and/or through the customer portal

Ask for information
Solicita información de

Hereditary pancreatic cancer

"*" indicates required fields

Consentimiento*
This field is for validation purposes and should be left unchanged.
Technique: NGS capture panel

Turnaround time (TAT): 15 days

Ref. S-202211931

Hereditary pancreatic cancer: View panel
  • APC
  • ATM
  • BRCA1
  • BRCA2
  • CDKN2A
  • FANCG
  • MLH1
  • MSH2
  • MSH6
  • PALB2
  • PMS2
  • PRSS1
  • STK11
  • TP53

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.

Related panels
Hereditary pancreatic cancer [14 genes]